Breakdown | ||||
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
198.20B | 175.39B | 161.29B | 136.74B | 142.98B | Gross Profit |
50.80B | 57.38B | 55.65B | 50.59B | 53.96B | EBIT |
2.44B | -6.17B | -1.75B | -457.88M | 4.56B | EBITDA |
30.50B | 477.14M | 4.05B | 5.02B | 9.32B | Net Income Common Stockholders |
1.38B | 538.72M | 10.08B | 8.00B | 14.80B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
152.65B | 157.80B | 164.77B | 173.54B | 158.04B | Total Assets |
808.39B | 823.15B | 806.28B | 767.72B | 715.68B | Total Debt |
233.57B | 228.36B | 257.87B | 250.87B | 224.97B | Net Debt |
153.26B | 128.29B | 161.59B | 145.15B | 131.33B | Total Liabilities |
599.81B | 623.52B | 603.16B | 574.64B | 534.76B | Stockholders Equity |
124.94B | 121.52B | 131.00B | 127.81B | 122.55B |
Cash Flow | Free Cash Flow | |||
-3.35B | -5.45B | -9.64B | 2.73B | 2.91B | Operating Cash Flow |
9.82B | 1.76B | -3.32B | 8.89B | 7.83B | Investing Cash Flow |
17.59B | 35.58B | -536.96M | 612.52M | -12.44B | Financing Cash Flow |
-39.67B | -38.12B | -3.66B | 2.29B | -4.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £147.39B | 8.47 | 13.62% | 6.18% | 3.98% | 5.43% | |
76 Outperform | $180.79B | 10.30 | 11.23% | 6.63% | -2.77% | 4.04% | |
71 Outperform | HK$209.65B | 12.01 | 2.88% | 5.13% | 20.91% | -29.29% | |
66 Neutral | €818.17B | 5.29 | 19.25% | 8.41% | 5.62% | -0.74% | |
64 Neutral | HK$123.53B | 14.06 | 11.92% | 2.10% | 17.34% | 28.21% | |
63 Neutral | $4.27B | 11.40 | 5.38% | 214.75% | 4.10% | -8.98% | |
45 Neutral | HK$32.89B | 44.05 | -3.59% | 0.97% | -4.89% | -402.47% |
Fosun International Limited has announced a discloseable transaction concerning the acquisition of unlisted shares of Henlius. This acquisition involves multiple shareholders, with Ms. Tseng Chi-Ling being the largest shareholder of HenLink, the seller. This strategic move is expected to enhance Fosun’s market positioning and potentially impact its stakeholders by expanding its investment portfolio.
Fosun International Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 5, 2025, in Shanghai, China. Key agenda items include the presentation of audited financial statements for 2024, the declaration of a final dividend, re-election of directors, and the reappointment of Ernst & Young as auditors. Additionally, resolutions will be considered for the authorization of share purchases and the issuance of new shares, which could impact the company’s market positioning and shareholder value.
Fosun International, through its subsidiary Fosun Pharma Industrial, has increased its stake in Henlius by acquiring additional shares, bringing its total ownership to 63.43%. This acquisition, conducted through a series of transactions, highlights Fosun’s strategic focus on expanding its influence in the pharmaceutical sector. The transactions are classified as discloseable under Hong Kong’s Listing Rules, indicating their significance to the company’s financial and operational strategies.
Fosun International Limited announced the resignation of Mr. Yu Qingfei from his position as a non-executive director, effective April 11, 2025, due to a reallocation of work. The company expressed gratitude for Mr. Yu’s contributions, and he confirmed no disagreements with the board, ensuring no issues for shareholders or the Hong Kong Stock Exchange.
Fosun International Limited has announced a final ordinary cash dividend of HKD 0.02 per share for the financial year ending December 31, 2024. The dividend reflects the company’s commitment to returning value to its shareholders, with the payment scheduled for July 16, 2025, following shareholder approval in June. This announcement underscores Fosun’s stable financial performance and its strategy to maintain investor confidence.
Fosun International reported a challenging financial year in 2024, with a loss attributable to owners of the parent amounting to RMB 4,348.9 million, compared to a profit in the previous year. Despite the financial setback, the company maintained stability in its core operations and continued its strategy of divesting non-core and heavy assets, amounting to approximately RMB 30 billion at the consolidated level. This strategic focus aims to streamline operations, reduce debt, and create long-term value for shareholders by concentrating on core industries and leveraging globalization and innovation capabilities.
Fosun International Limited has announced a change in the date for its board meeting, originally scheduled for March 31, 2025, to March 30, 2025. This meeting is crucial for approving the annual results for the year ending December 31, 2024, and considering the payment of a final dividend. The rescheduling is due to changes in work arrangements related to the annual results, which may impact the company’s operational timeline and stakeholder expectations.
Fosun International has issued a profit warning for the 2024 financial year, anticipating a significant loss due to a substantial adjustment in the carrying value of its investment in Cainiao Smart Logistics Network Limited. Despite this expected loss, the company’s core operations remain stable, with a clear strategic focus and robust industrial capabilities aimed at ensuring long-term growth.
Fosun International’s subsidiary, Fidelidade, has released its financial results for 2024, reporting total assets of EUR 22.05 billion and a net profit of EUR 253.15 million. This financial performance underscores Fidelidade’s robust position in the insurance market, reflecting its capability to generate substantial revenue and profit, which could positively impact Fosun’s overall financial health and appeal to investors.
Shanghai Yuyuan Tourist Mart, a subsidiary of Fosun International, reported a significant decline in its 2024 financial performance. The company’s revenue decreased by 19.30% compared to the previous year, and its net profit attributable to shareholders plummeted by 93.81%. These results highlight challenges in the company’s operations and could impact its market positioning and stakeholder confidence.
Fosun International Limited has announced that its board of directors will meet on March 31, 2025, to approve the annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
Fosun International announced the successful completion of a share buy-back of Fosun Tourism Group (FTG) through a scheme of arrangement, which has been sanctioned by the Grand Court and registered in the Cayman Islands. This transaction will lead to the withdrawal of FTG shares from the Hong Kong Stock Exchange, effective March 19, 2025. The company expressed gratitude to shareholders and business partners for their support and emphasized its commitment to FTG’s business development and leveraging group synergies.
Fosun International, through its indirect subsidiary Fosun Joygo, has entered into a Sale and Purchase Agreement with Hangzhou Tianyuan for the disposal of a significant equity interest in Guangzhou Taotall. Fosun Joygo plans to sell 43.9688% of its equity interest, while other shareholders, including Mr. Huang and Mr. Tang, will sell smaller portions. The transaction will be settled through the issuance of A Shares by Hangzhou Tianyuan and/or cash. This move will result in Fosun International no longer holding any equity interest in Guangzhou Taotall, potentially impacting its market positioning and stakeholder interests.